Source: Eur Respir J, 51 (2) 1702166; 10.1183/13993003.02166-2017
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Russell R. Kempker, M. Tobias Heinrichs, Ketino Nikolaishvili, Irina Sabulua, Nino Bablishvili, Shota Gogishvili, Zaza Avaliani, Brent P. Little, Adam Bernheim, Hartmut Derendorf, Henry M. Blumberg, Sergo Vashakidze, Charles A. Peloquin. A comparison of linezolid lung tissue concentrations among patients with drug-resistant tuberculosis. Eur Respir J, 51 (2) 1702166; 10.1183/13993003.02166-2017

Member's Comments

No comment yet.

Related content which might interest you: Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients Source: Eur Respir J 2013; 42: 1614-1621 Year: 2013 Clinical efficacy of once a day linezolid and azithromycin in the treatment of multi-drug resistant tuberculosis Source: Annual Congress 2007 - Drug-resistant and multidrug-resistant tuberculosis Year: 2007 Drug concentration in lung tissue in multidrug-resistant tuberculosis Source: Eur Respir J 2013; 42: 1750-1752 Year: 2013 Surgical treatment of patients with disseminated destructive multidrug resistant lung tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 489s Year: 2005 Method of treatment of destructive tuberculosis of single lung with extensively drug resistant mycobacteria tuberculosis Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions Year: 2011 Comorbidome in multidrug-resistant tuberculosis patients Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020 Treatment results in patients with drug resistant pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 612s Year: 2002 Susceptibility of Mycobacterium tuberculosis strains to fluoquinolones, obtained from chronic patients with multidrug resistant pulmonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 315s Year: 2001 Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains Source: Eur Respir J 2015; 45: 285-287 Year: 2015 Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains Source: Eur Respir J 2015; 45: 287-289 Year: 2015 The efficacy of treatment of patients with drug resistant tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 661s Year: 2007 Efficacy and safety of linezolid for the treatment of multidrug resistant tuberculosis (MDR-TB) and disease by non tuberculous mycobacteria (NTM) Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions Year: 2011 Results of surgical treatment in patients with multi drug resistent lung tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 135s Year: 2006 Bedaquiline in the treatment of multi-drug resistant non-tuberculous mycobacteria soft tissue infections: a case series Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease Year: 2021 Pharmacokinetics of ertapenem in patients with multidrug-resistant tuberculosis Source: Eur Respir J 2016; 47: 1229-1234 Year: 2016 Diaskintest at patients after successful treatment of lung tuberculosis Source: International Congress 2017 – Migrants and screening Year: 2017 Detection of isoniazid or rifampin resistant Mycobacterium tuberculosis in patients with cavity and previously treated for tuberculosis - usefulness of rapid drug susceptibility test with sputum samples by reverse hybridization assay Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis Year: 2005 Antituberculosis activity of rifabutin in vitro and in patients with pulmonary drug resistant tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 524s Year: 2003 A study of role of rifabutin as an adjuvant in management of cases with multi-drug resistant pulmonary tuberculosis Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis Year: 2007 Comparison of moxifloxacin and ofloxacin in treatment of multidrug resistant pulmonary tuberculosis Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012